These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8558670)

  • 1. Value of systematic transition zone biopsies in the early detection of prostate cancer.
    Bazinet M; Karakiewicz PI; Aprikian AG; Trudel C; Aronson S; Nachabé M; Péloquin F; Dessureault J; Goyal M; Zheng W; Bégin LR; Elhilali MM
    J Urol; 1996 Feb; 155(2):605-6. PubMed ID: 8558670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
    Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A
    Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial.
    Presti JC; Chang JJ; Bhargava V; Shinohara K
    J Urol; 2000 Jan; 163(1):163-6; discussion 166-7. PubMed ID: 10604337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values.
    Keetch DW; Catalona WJ
    J Urol; 1995 Nov; 154(5):1795-7. PubMed ID: 7563349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical usefulness of routine biopsy of the transition zone in the diagnosis of prostate cancer].
    Morote Robles J; López Pacios M; Encabo Duró G; de Torres Ramírez I
    Actas Urol Esp; 1999; 23(7):583-6. PubMed ID: 10488612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer diagnosis with prostate specific antigen greater than 10 ng./ml. and negative peripheral zone prostate biopsy.
    Fowler JE; Condon MA; Terrell FL
    J Urol; 1996 Oct; 156(4):1370-4. PubMed ID: 8808874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?
    Djavan B; Ravery V; Zlotta A; Dobronski P; Dobrovits M; Fakhari M; Seitz C; Susani M; Borkowski A; Boccon-Gibod L; Schulman CC; Marberger M
    J Urol; 2001 Nov; 166(5):1679-83. PubMed ID: 11586201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications for transition zone biopsy in the detection of prostatic carcinoma.
    Fleshner NE; Fair WR
    J Urol; 1997 Feb; 157(2):556-8. PubMed ID: 8996355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
    Iwaki H; Kajita Y; Shimizu Y; Yamauchi T
    Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased detection of clinically significant prostate cancer by additional sampling from the anterior lateral horns of the peripheral zone in combination with the standard sextant biopsy.
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2004 Jun; 11(6):402-6. PubMed ID: 15157210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No reason for immediate repeat sextant biopsy after negative initial sextant biopsy in men with PSA level of 4.0 ng/mL or greater (ERSPC, Rotterdam).
    Roobol MJ; van der Cruijsen IW; Schröder FH
    Urology; 2004 May; 63(5):892-7; discussion 897-9. PubMed ID: 15134973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of transition zone biopsy in systematic prostate biopsy].
    Nakata S; Inoue M; Takezawa Y; Kobayashi M; Kuribara H; Shinya H; Kurita S
    Hinyokika Kiyo; 1998 Aug; 44(8):553-6. PubMed ID: 9783190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men.
    Akduman B; Alkibay T; Tuncel A; Bozkirli I
    Can J Urol; 2000 Oct; 7(5):1104-9. PubMed ID: 11114873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
    Haese A; Dworschack RT; Partin AW
    J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing prostate cancer detection: 8 versus 12-core biopsy protocol.
    de la Rosette JJ; Wink MH; Mamoulakis C; Wondergem N; ten Kate FJ; Zwinderman K; de Reijke TM; Wijkstra H
    J Urol; 2009 Oct; 182(4):1329-36. PubMed ID: 19683269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
    Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
    Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: relationship to transition zone volume.
    Stamey TA; Yemoto CE
    J Urol; 2000 Jan; 163(1):119-26. PubMed ID: 10604328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of transition zone sampling by TURP in patients with raised PSA and multiple negative transrectal ultrasound-guided prostatic biopsies.
    Radhakrishnan S; Dorkin TJ; Sheikh N; Greene DR
    Prostate Cancer Prostatic Dis; 2004; 7(4):338-42. PubMed ID: 15365579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.
    Eskicorapci SY; Guliyev F; Akdogan B; Dogan HS; Ergen A; Ozen H
    J Urol; 2005 May; 173(5):1536-40. PubMed ID: 15821481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.